Literature DB >> 30617565

Tobacco dependence is associated with increased risk for multi-morbid clustering of posttraumatic stress disorder, depressive disorder, and pain among post-9/11 deployed veterans.

Jennifer R Fonda1,2, Kristin L Gregor3,4, Catherine B Fortier5,6, Erica R Scioli-Salter3,4,7, Regina E McGlinchey5,6, Ann Rasmusson3,4,7.   

Abstract

RATIONALE: Tobacco use is highly prevalent among individuals with posttraumatic stress disorder (PTSD), depressive disorders, and pain. Research has revealed pairwise relationships among these conditions but has not examined more complex relationships that may influence symptom severity, chronicity, and treatment outcome.
OBJECTIVE: To examine the clustering of current PTSD, depressive disorders, and clinically significant pain according to current tobacco use and dependence among post-9/11 deployed veterans.
METHODS: Logistic regression was used to examine the clustering of these conditions in relationship to current tobacco use/dependence, while adjusting for age and total combat exposure, in 343 post-9/11 deployed veterans enrolled in the Translational Research Center for TBI and Stress Disorders (TRACTS) cohort (Mage = 32.1 + 8.3 years; 38% current tobacco use; 25% low and 12% moderate/high tobacco dependence).
RESULTS: A three-way clustering of PTSD, depressive disorder, and pain was more likely than any single or pairwise combination of these conditions in moderate/high tobacco-dependent veterans compared to tobacco non-users (adjusted ORs = 3.50 to 4.18). This multi-morbidity cluster also was associated with increased PTSD severity.
CONCLUSIONS: Moderate to high dependence on tobacco is associated with substantially increased clustering of PTSD, depression, and clinically significant pain in veterans. Research examining synergistic interactions among these conditions, biological vulnerabilities shared among them, and the direct impact of tobacco use on the pathophysiology of PTSD, depression, and pain is needed. The results of such work may spur development of more effective integrated treatments to reduce the negative impact of these multi-morbid conditions on veterans' wellbeing and long-term health.

Entities:  

Keywords:  Depression; PTSD comorbidity; Pain; Tobacco use

Mesh:

Year:  2019        PMID: 30617565     DOI: 10.1007/s00213-018-5155-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  55 in total

1.  Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care.

Authors:  Charles W Hoge; Carl A Castro; Stephen C Messer; Dennis McGurk; Dave I Cotting; Robert L Koffman
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

Review 2.  Smoking and drinking as complementary behaviours.

Authors:  Robin Room
Journal:  Biomed Pharmacother       Date:  2004-03       Impact factor: 6.529

Review 3.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.

Authors:  Robert H Dworkin; Dennis C Turk; John T Farrar; Jennifer A Haythornthwaite; Mark P Jensen; Nathaniel P Katz; Robert D Kerns; Gerold Stucki; Robert R Allen; Nicholas Bellamy; Daniel B Carr; Julie Chandler; Penney Cowan; Raymond Dionne; Bradley S Galer; Sharon Hertz; Alejandro R Jadad; Lynn D Kramer; Donald C Manning; Susan Martin; Cynthia G McCormick; Michael P McDermott; Patrick McGrath; Steve Quessy; Bob A Rappaport; Wendye Robbins; James P Robinson; Margaret Rothman; Mike A Royal; Lee Simon; Joseph W Stauffer; Wendy Stein; Jane Tollett; Joachim Wernicke; James Witter
Journal:  Pain       Date:  2005-01       Impact factor: 6.961

4.  Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. Implications for depression.

Authors:  M Kaminska; J Harris; K Gijsbers; B Dubrovsky
Journal:  Brain Res Bull       Date:  2000-06       Impact factor: 4.077

5.  Pain predicts longer time to remission during treatment of recurrent depression.

Authors:  Jordan F Karp; John Scott; Patricia Houck; Charles F Reynolds; David J Kupfer; Ellen Frank
Journal:  J Clin Psychiatry       Date:  2005-05       Impact factor: 4.384

Review 6.  Smoking and mental illness.

Authors:  S Leonard; L E Adler; K Benhammou; R Berger; C R Breese; C Drebing; J Gault; M J Lee; J Logel; A Olincy; R G Ross; K Stevens; B Sullivan; R Vianzon; D E Virnich; M Waldo; K Walton; R Freedman
Journal:  Pharmacol Biochem Behav       Date:  2001-12       Impact factor: 3.533

7.  Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire.

Authors:  E S Kubany; S N Haynes; M B Leisen; J A Owens; A S Kaplan; S B Watson; K Burns
Journal:  Psychol Assess       Date:  2000-06

8.  A second look at comorbidity in victims of trauma: the posttraumatic stress disorder-major depression connection.

Authors:  N Breslau; G C Davis; E L Peterson; L R Schultz
Journal:  Biol Psychiatry       Date:  2000-11-01       Impact factor: 13.382

9.  Smoking and mental illness: A population-based prevalence study.

Authors:  K Lasser; J W Boyd; S Woolhandler; D U Himmelstein; D McCormick; D H Bor
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

Review 10.  The neuroendocrinology of posttraumatic stress disorder: new directions.

Authors:  Ann M Rasmusson; Meena Vythilingam; Charles A Morgan
Journal:  CNS Spectr       Date:  2003-09       Impact factor: 3.790

View more
  1 in total

1.  Identifying co-occurrence and clustering of chronic diseases using latent class analysis: cross-sectional findings from SAGE South Africa Wave 2.

Authors:  Glory Chidumwa; Innocent Maposa; Barbara Corso; Nadia Minicuci; Paul Kowal; Lisa K Micklesfield; Lisa Jayne Ware
Journal:  BMJ Open       Date:  2021-01-29       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.